Anabolic Steroids Control Act of 1990Anabolic steroids are drugs that replicate the effects of male clen kuumavesipesuri, like testosterone, on the body. Steroids increase cell anabolic steroids control act of proteins, which then results in a buildup of tissues in the cells, particularly in the muscles. These substances also develop and maintain masculine qualities, anabolic steroids control act as enhancing the vocal cords, testicles and body hair. Long-term use of anabolic steroids can have sct negative impact on the anabolic steroids control act and, conversely, their use can also result in unnatural physical abilities. These abilities can unfairly impact the results of sporting events, such as bodybuilding and baseball. Although it was initially recommended that anabolic anabolicc be added to the list of substances coming under the Controlled Substances Act, many in the medical and anti inflammatory steroids injection enforcement community opposed such an action, claiming that steroids lacked both the physical and psychological dependence required for this actt of classification.
Anabolic Steroid Control Act of (; th Congress S. ) - ghid-supraveghere.info
Should taxpayer money be used to pay for children of military members to afford private religious school tuition? Congress members get some lifetime benefits that virtually no other job in America offers to retired employees. Should that practice no… Apr 18, Add a note about this bill.
Your note is for you and will not be shared with anyone. Because you are a member of panel , your positions on legislation and notes below will be shared with the panel administrators. The text of the bill below is as of Sep 16, Referred to Senate Committee.
Received; read twice and referred to the Committee on the Judiciary. To amend the Controlled Substances Act to more effectively regulate anabolic steroids. Section 41 of the Controlled Substances Act 21 U. Subject to clause ii , a drug or hormonal substance other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone that is not listed in subparagraph A and is derived from, or has a chemical structure substantially similar to, 1 or more anabolic steroids listed in subparagraph A shall be considered to be an anabolic steroid for purposes of this Act if—.
A substance shall not be considered to be a drug or hormonal substance for purposes of this subparagraph if it—. In accordance with section a , any person claiming the benefit of an exemption or exception under clause ii shall bear the burden of going forward with the evidence with respect to such exemption or exception. Section of the Controlled Substances Act 21 U. The Attorney General may issue a temporary order adding a drug or other substance to the definition of anabolic steroids if the Attorney General finds that—.
An order issued under paragraph 1 shall not take effect until 30 days after the date of the publication by the Attorney General of a notice in the Federal Register of the intention to issue such order and the grounds upon which such order is to be issued. The order shall expire not later than 24 months after the date it becomes effective, except that the Attorney General may, during the pendency of proceedings under paragraph 6 , extend the temporary scheduling order for up to 6 months. The Attorney General shall transmit notice of an order proposed to be issued under paragraph 1 to the Secretary of Health and Human Services.
In issuing an order under paragraph 1 , the Attorney General shall take into consideration any comments submitted by the Secretary in response to a notice transmitted pursuant to this paragraph. A temporary scheduling order issued under paragraph 1 shall be vacated upon the issuance of a permanent scheduling order under paragraph 6. An order issued under paragraph 1 is not subject to judicial review.
The Attorney General may, by rule, issue a permanent order adding a drug or other substance to the definition of anabolic steroids if such drug or other substance satisfies the criteria for being considered an anabolic steroid under section Such rulemaking may be commenced simultaneously with the issuance of the temporary order issued under paragraph 1. It shall be unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, an anabolic steroid or product containing an anabolic steroid, unless the steroid or product bears a label clearly identifying an anabolic steroid or product containing an anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry IUPAC.
A product described in subparagraph B is exempt from the International Union of Pure and Applied Chemistry nomenclature requirement of this subsection if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act. A product is described in this subparagraph if the product—.
For purposes of this subparagraph, a violation is defined as each instance of importation, exportation, manufacturing, distribution, or possession with intent to manufacture or distribute, in violation of paragraph 16 of subsection a. For purposes of this paragraph, the term at the retail level refers to products sold, or held for sale, directly to the consumer for personal use. Each package, container or other separate unit containing an anabolic steroid that is distributed, dispensed, or possessed with intent to distribute or dispense at the retail level in violation of such paragraph 16 of subsection a shall be considered a separate violation.
The Attorney General may publish in the Federal Register or on the website of the Drug Enforcement Administration a list of products which the Attorney General has determined, based on substantial evidence, contain an anabolic steroid and are not labeled in accordance with this Act and the amendments made by this Act.
The absence of a product from the list referred to in subsection a shall not constitute evidence that the product does not contain an anabolic steroid. Passed the House of Representatives September 15, Follow us on Twitter and Facebook for updates about legislation in Congress. Sign up for our articles by email and then get legislative alerts for your reps or issues you care about.
Support our work so we can bring you more information about what Congress is doing each day. Toggle navigation Search GovTrack govtrack. What is the law? Omnibus spending bill enacted: House vote Senate vote. Designer Anabolic Steroid Control Act of This bill has 5 versions.
Select a version to view: Passed Congress May 29, Introduced Sep 15, Reported by House Committee Sep 15, Passed the House Sep 16, Referred to Senate Committee. Compare to a previous version to see how the bill has changed: Select Other Version Jan 1, Compare this bill to another bill: Save your opinion on this bill on a six-point scale from strongly oppose to strongly support.
Primary Source Government Publishing Office. About Ads Hide These Ads. C i Subject to clause ii , a drug or hormonal substance other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone that is not listed in subparagraph A and is derived from, or has a chemical structure substantially similar to, 1 or more anabolic steroids listed in subparagraph A shall be considered to be an anabolic steroid for purposes of this Act if— I the drug or substance has been created or manufactured with the intent of producing a drug or other substance that either— aa promotes muscle growth; or bb otherwise causes a pharmacological effect similar to that of testosterone; or II the drug or substance has been, or is intended to be, marketed or otherwise promoted in any manner suggesting that consuming it will promote muscle growth or any other pharmacological effect similar to that of testosterone.
B A product is described in this subparagraph if the product— i is the subject of an approved application as described in section b or j of the Federal Food, Drug, and Cosmetic Act; or ii is exempt from the provisions of section of such Act relating to new drugs because— I it is intended solely for investigational use as described in section i of such Act; and II such product is being used exclusively for purposes of a clinical trial that is the subject of an effective investigational new drug application.
Sign Up Get Alerts.